Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (formaldehyde inactivated) Completed Phase 4 Trials for Pain / Adverse Drug Reaction (ADR) / Injection Site Reactions / Quality of Life (QOL) Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT05007041Simultaneous RZV and aIIV4 Vaccination
NCT03183908FLUADĀ® vs. FluzoneĀ® High-Dose Study